Get the Stockscreener App
12.78
0.51%
0.04
Clearpoint Neuro Inc stock is traded at $12.78, with a volume of 56,870.
It is up +0.51% in the last 24 hours and up +14.23% over the past month.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.
See More
Previous Close:
$12.74
Open:
$12.69
24h Volume:
56,870
Relative Volume:
0.28
Market Cap:
$350.74M
Revenue:
$23.96M
Net Income/Loss:
$-22.09M
P/E Ratio:
-15.04
EPS:
-0.85
Net Cash Flow:
$-14.77M
1W Performance:
-1.65%
1M Performance:
+14.23%
6M Performance:
+118.14%
1Y Performance:
+109.92%
1-Day Range:
$12.39
$12.91
1-Week Range:
$12.04
$13.24
52-Week Range:
$4.05
$14.12
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Name
Clearpoint Neuro Inc
Sector
Industry
Phone
(949) 900-6833
Address
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-16-23 | Resumed | B. Riley Securities | Buy |
| Apr-05-22 | Resumed | B. Riley Securities | Buy |
| Mar-18-21 | Initiated | Lake Street | Buy |
| Jul-17-20 | Initiated | B. Riley FBR | Buy |
Clearpoint Neuro Inc Stock (CLPT) Latest News
(CLPT) Trading Report - Stock Traders Daily
Vanguard Group Inc's Strategic Acquisition in ClearPoint Neuro I - GuruFocus.com
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 - AccessWire
ClearPoint Neuro: Investors Enamored With Its Growth Prospects (NASDAQ:CLPT) - Seeking Alpha
ClearPoint Neuro (CLPT) Set to Announce Quarterly Earnings on Thursday - MarketBeat
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Sees Significant Increase in Short Interest - MarketBeat
Taylor Frigon Capital Management LLC Has $4.20 Million Stock Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
CLPTClearPoint Neuro, Inc. Latest Stock News & Market Updates - StockTitan
ClearPoint Neuro (CLPT) Soars 6.9%: Is Further Upside Left in the Stock? - MSN
Investors bid ClearPoint Neuro (NASDAQ:CLPT) up US$51m despite increasing losses YoY, taking five-year CAGR to 27% - Simply Wall St
ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024 - ForexTV.com
ClearPoint Neuro, Inc. (CLPT): A Bear Case Theory - Insider Monkey
Cubist Systematic Strategies LLC Takes $419,000 Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Cubist Systematic Strategies LLC Acquires Shares of 77,750 ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
Marshall Wace LLP Buys 38,984 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Squarepoint Ops LLC Takes $549,000 Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
Renaissance Technologies LLC Acquires 144,088 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
Cubist Systematic Strategies LLC Takes Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
Learn to Evaluate (CLPT) using the Charts - Stock Traders Daily
Point72 Asia Singapore Pte. Ltd. Makes New Investment in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
(CLPT) Investment Analysis and Advice - Stock Traders Daily
Believ acquires’ SMS Public EV Charging to accelerate charge point rollout - Fleet World
FDA Clears Neuroblade System For Minimally Invasive Neurosurgery - MPO-mag
The Good News and Bad News From ChargePoint's Q2 Results - sharewise
Investors Appear Satisfied With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Prospects As Shares Rocket 28% - Simply Wall St
It makes sense and dollars to buy ClearPoint Neuro Inc (CLPT) stock - SETE News
Is ClearPoint Neuro Inc (CLPT) a good investment opportunity? - US Post News
57,015 Shares in ClearPoint Neuro, Inc. (NASDAQ:CLPT) Purchased by Rinkey Investments - MarketBeat
Clearpoint Neuro shares target raised by Lake Street with Buy rating - Investing.com
Lake Street Capital Raises ClearPoint Neuro (NASDAQ:CLPT) Price Target to $15.00 - Defense World
ClearPoint Neuro announces early repayment of convertible note - Medical Buyer
ClearPoint Neuro Announces Early Repayment of $10 Million Note - ForexTV.com
ClearPoint Neuro repays $10 million note ahead of schedule - Investing.com
ClearPoint Neuro Preempts Convertible Note Obligations - TipRanks
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Down 5.9% in July - MarketBeat
Short Interest in ClearPoint Neuro, Inc. (NASDAQ:CLPT) Drops By 5.9% - Defense World
Price T Rowe Associates Inc. MD Acquires 1,813 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Is ClearPoint Neuro (NASDAQ:CLPT) Weighed On By Its Debt Load? - Simply Wall St
ClearPoint: Growth Tailwinds Are Only Just Beginning To Emerge (Rating Downgrade) - Seeking Alpha
B. Riley Analysts Cut Earnings Estimates for ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
ClearPoint Neuro, Inc. Expected to Post Q3 2024 Earnings of ($0.19) Per Share (NASDAQ:CLPT) - Defense World
Riding the Waves: A Guide to Investing in CLPT Stock - The InvestChronicle
ClearPoint Neuro: My Favorite Growth Stock (NASDAQ:CLPT) - Seeking Alpha
Earnings call: ClearPoint Neuro sees record revenue of $7.9 million By Investing.com - Investing.com Canada
Earnings call: ClearPoint Neuro sees record revenue of $7.9 million - Investing.com
ClearPoint Neuro, Inc. (CLPT) Q2 2024 Earnings Call Transcript - Seeking Alpha
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
ClearPoint Neuro Reports Second Quarter 2024 Results - StockTitan
Financial Review: TriSalus Life Sciences (NASDAQ:TLSI) & ClearPoint Neuro (NASDAQ:CLPT) - Defense World
Clearpoint Neuro Inc Stock (CLPT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):